Categories AlphaGraphs, Earnings, Health Care

Earnings: Highlights of Eli Lilly’s (LLY) Q1 2022 results

Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers also surpassed the consensus estimates.

Eli Lilly Q1 2022 earnings infographic

The Indianapolis-based pharmaceutical company said its revenues grew15% year-over-year to $7.81 billion in the first quarter as volumes increased by 20%. Experts had predicted a slower revenue growth.

The positive top-line performance translated into a 63% increase in net earnings, on an adjusted basis, to $2.62 per share, which also came in above the market’s projection. Unadjusted profit increased to $1.9 billion or $2.10 per share from $1.36 billion or $1.49 per share in the first quarter of 2021.


Read management/analysts’ comments on Eli Lilly’s Q1 2022 earnings


“Lilly delivered another quarter of volume-driven revenue growth led by key products and anticipates 2022 to be an exciting year with several potential approvals and new pipeline events. With the depth of our pipeline, and growth of our medicines in the market, we are well-positioned to help address health challenges in areas of significant unmet medical need, such as obesity, Alzheimer’s disease, and cancer,” said David Ricks, CEO of Eli Lilly.

Prior Performance

  • Eli Lilly reports Q2 2020 earnings results

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top